Susceptibility testing and molecular classification of Paecilomyces spp
- PMID: 18519716
- PMCID: PMC2493137
- DOI: 10.1128/AAC.00538-08
Susceptibility testing and molecular classification of Paecilomyces spp
Abstract
In vitro susceptibility profiles of 58 Paecilomyces clinical isolates are reported. Amphotericin B, itraconazole, and echinocandins showed poor activity against Paecilomyces lilacinus, while the new triazoles were active against it. Paecilomyces variotii exhibited a different susceptibility pattern, being susceptible to most antifungal agents apart from voriconazole and ravuconazole.
Figures
References
-
- Aberkane, A., M. Cuenca-Estrella, A. Gomez-Lopez, E. Petrikkou, E. Mellado, A. Monzon, J. L. Rodriguez-Tudela, and the Eurofung Network. 2002. Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J. Antimicrob. Chemother. 50:719-722. - PubMed
-
- Antachopoulos, C., T. J. Walsh, and E. Roilides. 2007. Fungal infections in primary immunodeficiencies. Eur. J. Pediatr. 166:1099-1117. - PubMed
-
- Castro, L. G., A. Salebian, and M. N. Sotto. 1990. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections. J. Med. Vet. Mycol. 28:15-26. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
